human gli1 (Addgene inc)
Addgene inc is a verified supplier 
93
Structured Review
Addgene inc
human gli1
Human Gli1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+gli1/Gli1+(Plasmid+%2334996)/pm40345509-79-6-30
Average 93 stars, based on 16 article reviews
Human Gli1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+gli1/Gli1+(Plasmid+%2334996)/pm40345509-79-6-30
Average 93 stars, based on 16 article reviews
human gli1 - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Mutagenesis:Article Title: WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function. Article Snippet: After mechanical disruption, tumors were incubated in Dulbecco’s Modified Eagle Medium (DMEM)/F12 (Euroclone, Milan, Italy) and cells were grown in DMEM/F12 with 10% fetal bovine serum (FBS).14 The identity of melanoma cells was verified by immunocytochemistry, as described.51 Drugs used for treatments were puromycin (2mg/ml), CCT007093 (CCT, 10 mM), CHX (80mg/ml), tomatidine (Tom; 2.5mM) (Sigma-Aldrich, St Louis, MO, USA) and Cyc (2.5 mM, TRC, Toronto, Canada). .. Plasmids, mutagenesis and lentiviral vectors Myc-tagged Plasmid Preparation:Article Title: ASPM Activates Hedgehog and Wnt Signaling to Promote Small Cell Lung Cancer Stemness and Progression. Article Snippet: .. The lentivirus-mediated OE vector of Article Title: Acquired resistance to vemurafenib restrains thyroid cancer stem cell self-renewal by suppressing STAT3 activation. Article Snippet: Vemurafenib (PLX4032) is a B-Raf kinase-specific inhibitor that has been approved for treating BRAF-mutated melanoma but is ineffective in treating thyroid cancer.. Cancer stem cells (CSCs) play an important role in drug resistance (DR).. Our present study aims to determine the status of CSCs in thyroid cancer cells that have acquired adaptive drug resistance to PLX4032. Expressing:Article Title: Acquired resistance to vemurafenib restrains thyroid cancer stem cell self-renewal by suppressing STAT3 activation. Article Snippet: Vemurafenib (PLX4032) is a B-Raf kinase-specific inhibitor that has been approved for treating BRAF-mutated melanoma but is ineffective in treating thyroid cancer.. Cancer stem cells (CSCs) play an important role in drug resistance (DR).. Our present study aims to determine the status of CSCs in thyroid cancer cells that have acquired adaptive drug resistance to PLX4032. |